 |
|
|
| |
Elevated Tenofovir Exposure via Intensive Pharmacokinetic Monitoring is Associated with Progressive Kidney Function Decline
|
| |
| |
Reported by Jules Levin
CROI 2015 Feb 23-26, Seattle, WA
Sanjiv M. Baxi, MS, MD, MPH1,2, Rebecca Scherzer, PhD3, Ruth Greenblatt, MD4, Howard Minkoff, MD5, Kathryn Anastos, MD6, MardgeCohen, MD7, Mary A. Young, MD8, Monica Gandhi, MD, MPH1, and Michael G. Shlipak, MD, MPH3, for the Women's Interagency HIV Study (WIHS)
1Department of Medicine, University of California, San Francisco, San Francisco, California, USA, and 2School of Public Health, University of California, Berkeley, Berkeley, California, USA, and Department Medicine, Veterans Affairs Hospital, San Francisco, California, USA, and 4Department of Clinical Pharmacy, University of California, San Francisco, San Francisco, California, USA, 5Division of Infectious Diseases, State University of New York, Downstate Medical Center, Brooklyn, New York, USA, and 6Departments of Medicine and Obstetrics and Gynecology and Women's Health, Albert Einstein College of Medicine, Bronx, New York, USA, and 7CORE Center/ Division of Infectious Diseases, John H. StrogerJr. Hospital of Cook County, Chicago, Illinois, USA, and 8Department of Medicine, Georgetown University Medical Center
|
| |
|
|
|
|
|
